CN1533278A - 萘并噻嗪正变构的ampa受体调节物(paarm) - Google Patents
萘并噻嗪正变构的ampa受体调节物(paarm) Download PDFInfo
- Publication number
- CN1533278A CN1533278A CNA028100832A CN02810083A CN1533278A CN 1533278 A CN1533278 A CN 1533278A CN A028100832 A CNA028100832 A CN A028100832A CN 02810083 A CN02810083 A CN 02810083A CN 1533278 A CN1533278 A CN 1533278A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- represent
- different
- randomly
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10123952.1 | 2001-05-17 | ||
| DE10123952A DE10123952A1 (de) | 2001-05-17 | 2001-05-17 | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1533278A true CN1533278A (zh) | 2004-09-29 |
Family
ID=7685080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA028100832A Pending CN1533278A (zh) | 2001-05-17 | 2002-05-15 | 萘并噻嗪正变构的ampa受体调节物(paarm) |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1404340A1 (ja) |
| JP (1) | JP2004529980A (ja) |
| KR (1) | KR20040007572A (ja) |
| CN (1) | CN1533278A (ja) |
| AR (1) | AR036332A1 (ja) |
| BG (1) | BG108324A (ja) |
| BR (1) | BR0209796A (ja) |
| CA (1) | CA2449189A1 (ja) |
| CO (1) | CO5550460A2 (ja) |
| CZ (1) | CZ20033112A3 (ja) |
| DE (1) | DE10123952A1 (ja) |
| EA (1) | EA006608B1 (ja) |
| EC (1) | ECSP034852A (ja) |
| EE (1) | EE200300566A (ja) |
| HR (1) | HRP20030933A2 (ja) |
| HU (1) | HUP0401273A3 (ja) |
| IL (1) | IL158642A0 (ja) |
| MX (1) | MXPA03010373A (ja) |
| NO (1) | NO20035088D0 (ja) |
| NZ (1) | NZ530154A (ja) |
| PL (1) | PL364053A1 (ja) |
| SK (1) | SK14222003A3 (ja) |
| UY (1) | UY27290A1 (ja) |
| WO (1) | WO2002100411A1 (ja) |
| YU (1) | YU90403A (ja) |
| ZA (1) | ZA200308466B (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111518058A (zh) * | 2020-05-29 | 2020-08-11 | 四川大学华西医院 | 一种噁噻嗪类化合物及其用途 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8039468B2 (en) * | 2006-08-31 | 2011-10-18 | The Governors Of The University Of Alberta | Method of inhibition of respiratory depression using positive allosteric AMPA receptor modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4345297A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
| US6346526B1 (en) * | 1998-06-25 | 2002-02-12 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| DE10004572A1 (de) * | 2000-02-02 | 2001-08-09 | Boehringer Ingelheim Pharma | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
-
2001
- 2001-05-17 DE DE10123952A patent/DE10123952A1/de not_active Withdrawn
-
2002
- 2002-05-15 CZ CZ20033112A patent/CZ20033112A3/cs unknown
- 2002-05-15 HU HU0401273A patent/HUP0401273A3/hu unknown
- 2002-05-15 KR KR10-2003-7014965A patent/KR20040007572A/ko not_active Application Discontinuation
- 2002-05-15 BR BR0209796-6A patent/BR0209796A/pt not_active Expired - Fee Related
- 2002-05-15 WO PCT/EP2002/005338 patent/WO2002100411A1/en not_active Application Discontinuation
- 2002-05-15 SK SK1422-2003A patent/SK14222003A3/sk unknown
- 2002-05-15 CN CNA028100832A patent/CN1533278A/zh active Pending
- 2002-05-15 PL PL02364053A patent/PL364053A1/xx not_active Application Discontinuation
- 2002-05-15 YU YU90403A patent/YU90403A/sh unknown
- 2002-05-15 EA EA200301167A patent/EA006608B1/ru not_active IP Right Cessation
- 2002-05-15 NZ NZ530154A patent/NZ530154A/en unknown
- 2002-05-15 JP JP2003503232A patent/JP2004529980A/ja not_active Abandoned
- 2002-05-15 MX MXPA03010373A patent/MXPA03010373A/es unknown
- 2002-05-15 EP EP02750931A patent/EP1404340A1/en not_active Withdrawn
- 2002-05-15 CA CA002449189A patent/CA2449189A1/en not_active Abandoned
- 2002-05-15 UY UY27290A patent/UY27290A1/es not_active Application Discontinuation
- 2002-05-15 IL IL15864202A patent/IL158642A0/xx unknown
- 2002-05-15 EE EEP200300566A patent/EE200300566A/xx unknown
- 2002-05-17 AR ARP020101827A patent/AR036332A1/es not_active Suspension/Interruption
-
2003
- 2003-10-30 ZA ZA200308466A patent/ZA200308466B/en unknown
- 2003-11-07 BG BG108324A patent/BG108324A/bg active Pending
- 2003-11-14 HR HR20030933A patent/HRP20030933A2/xx not_active Application Discontinuation
- 2003-11-14 NO NO20035088A patent/NO20035088D0/no not_active Application Discontinuation
- 2003-11-17 EC EC2003004852A patent/ECSP034852A/es unknown
- 2003-12-01 CO CO03105591A patent/CO5550460A2/es unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111518058A (zh) * | 2020-05-29 | 2020-08-11 | 四川大学华西医院 | 一种噁噻嗪类化合物及其用途 |
| CN111518058B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种噁噻嗪类化合物及其用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| NO20035088L (no) | 2003-11-14 |
| DE10123952A1 (de) | 2002-11-21 |
| YU90403A (sh) | 2006-05-25 |
| HUP0401273A3 (en) | 2006-11-28 |
| AR036332A1 (es) | 2004-09-01 |
| CO5550460A2 (es) | 2005-08-31 |
| SK14222003A3 (sk) | 2004-05-04 |
| HUP0401273A2 (hu) | 2004-10-28 |
| ZA200308466B (en) | 2004-05-24 |
| NO20035088D0 (no) | 2003-11-14 |
| BR0209796A (pt) | 2004-06-01 |
| CA2449189A1 (en) | 2002-12-19 |
| WO2002100411A1 (en) | 2002-12-19 |
| JP2004529980A (ja) | 2004-09-30 |
| NZ530154A (en) | 2005-09-30 |
| IL158642A0 (en) | 2004-05-12 |
| PL364053A1 (en) | 2004-12-13 |
| CZ20033112A3 (en) | 2004-03-17 |
| EA200301167A1 (ru) | 2004-06-24 |
| HRP20030933A2 (en) | 2004-04-30 |
| UY27290A1 (es) | 2002-12-31 |
| ECSP034852A (es) | 2003-12-24 |
| MXPA03010373A (es) | 2004-03-16 |
| EE200300566A (et) | 2004-02-16 |
| EA006608B1 (ru) | 2006-02-24 |
| EP1404340A1 (en) | 2004-04-07 |
| KR20040007572A (ko) | 2004-01-24 |
| BG108324A (bg) | 2004-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1099413C (zh) | 某些稠合n－吡咯甲酰苯胺;一类新的脑gaba受体配体 | |
| CN1218940C (zh) | 氧化氮合酶抑制剂 | |
| CN1097054C (zh) | 三环类吡唑衍生物及其组合物 | |
| CN1816544A (zh) | 免疫抑制剂化合物和组合物 | |
| CN1835936A (zh) | 用于治疗阿尔茨海默氏病的大环β－分泌酶抑制剂 | |
| CN1527814A (zh) | 氧化氮合酶抑制剂磷酸盐 | |
| CN1123571C (zh) | 用作nmda受体拮抗剂的1－(3－杂芳基丙基－或－丙－2－烯基)－4－苄基哌啶 | |
| CN101052618A (zh) | 用作治疗阿尔茨海默氏病的β－分泌酶抑制剂的2－氨基吡啶化合物 | |
| CN1541216A (zh) | 8-甲氧基-(1,2,4)三唑并(1,5-a)吡啶衍生物及其作为腺苷受体配体的应用 | |
| CN1761644A (zh) | 4－氨基－2－丁烯酰氯的合成以及其在制备3－氰基喹啉中的应用 | |
| CN1399633A (zh) | 嘧啶衍生物 | |
| CN1027369C (zh) | 兴奋性氨基酸拮抗剂的制备方法 | |
| CN1071754C (zh) | 嘧啶基吡唑衍生物 | |
| CN1784230A (zh) | 烟碱性乙酰胆碱受体的正向调节剂 | |
| CN1450996A (zh) | 2－胍基－4－芳基喹唑啉 | |
| CN1104017A (zh) | 取代的(芳烷氧基苄基)氨基丙酰胺衍生物及其制备方法 | |
| CN101054380A (zh) | 用作细胞周期依赖性蛋白激酶抑制剂的吡唑并嘧啶类衍生物 | |
| CN1170814C (zh) | 用于强化胆碱能活性的酰胺化合物 | |
| CN1726209A (zh) | 3－取代的－4－嘧啶酮衍生物 | |
| CN1256337C (zh) | 抗抑郁的7,8－二氢－1,6,9－三氧杂－3－氮杂－环戊二烯并[a]萘的氮杂环基甲基衍生物 | |
| CN1267434C (zh) | 抗抑郁的(SSSRI)7,8－二氢－3H－6,9－二氧杂－1,3－二氮杂环戊二烯并[a]萘的氮杂环基甲基衍生物 | |
| CN1533278A (zh) | 萘并噻嗪正变构的ampa受体调节物(paarm) | |
| CN1261414C (zh) | 作为单胺氧化酶(mao－b)抑制剂的吡啶酰氨基衍生物 | |
| CN1051545C (zh) | 5－(芳氧基甲基)噁唑啉,其制备方法和含它们的药物组合物 | |
| CN1514825A (zh) | 可用于反流病的新化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1069543 Country of ref document: HK |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1069543 Country of ref document: HK |